ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
129 hedge funds and large institutions have $545M invested in Array Biopharma Inc in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
12% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 41
60% less call options, than puts
Call options by funds: $1.42M | Put options by funds: $3.55M
Holders
129
Holding in Top 10
5
Calls
$1.42M
Puts
$3.55M
Top Buyers
1 | +$28.4M | |
2 | +$14.6M | |
3 | +$5.47M | |
4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.55M |
5 |
CNB
City National Bank
Beverly Hills,
California
|
+$1.54M |
Top Sellers
1 | -$9.73M | |
2 | -$4.65M | |
3 | -$3.42M | |
4 |
TA
Teachers Advisors
New York
|
-$2.93M |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.65M |